2024
DOI: 10.3892/mmr.2024.13376
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

S100A16 stabilizes the ITGA3‑mediated ECM‑receptor interaction pathway to drive the malignant properties of lung adenocarcinoma cells via binding MOV10

Abstract: Lung adenocarcinoma (LUAD) is highly associated with lung cancer-associated mortality. Notably, S100 calcium-binding protein A16 (S100A16) has been increasingly considered to have prognostic value in LUAD; however, the underlying mechanism remains unknown. In the present study, S100A16 expression levels in LUAD tissues and cells were respectively analyzed by the UALCAN database and western blotting. Cell Counting Kit-8 and 5-ethynyl-2′-deoxyuridine assays were used to examine cell proliferation, whereas wound … Show more

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1
1
0

Citation Types

0
2
0
0

Year Published

Range
2025
2025
2026
2026

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations

Cited by 6 publications

(2 citation statements)
references

References 42 publications

0
2
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…In LUAD, early disease appears to co-opt a transitional injury/plasticity state dependent on a KRAS-ITGA3-SRC axis [ 32 ], suggesting ITGA3 contributes to the initiation-phase circuitry. At the post-transcriptional level, S100A16 stabilizes ITGA3 mRNA via MOV10 to maintain ECM-receptor signaling and malignant phenotypes in LUAD [ 33 ]. In glioblastoma, nanoparticle-delivered si-lncRNA NONHSAT159592.1 suppresses proliferation, Epithelial–Mesenchymal Transition (EMT), and invasion through ITGA3-related pathway, and ITGA3 overexpression reverses these inhibitory effects [ 34 ], directly supporting an ITGA3-anchored pro-invasive signaling route.…”
Section: Discussion
mentioning
confidence: 99%